Current Liabilities: The sum of all liabilities classified as current for having maturities of less than one year.
Emmaus Life Sciences, Inc. (EMMA) had Current Liabilities of $64.17M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$3.38M |
|
$-2.08M |
|
$0.25M |
|
$3.13M |
|
$2.68M |
|
$0.69M |
|
$-2.19M |
|
$-1.50M |
|
$-1.50M |
|
$-2.08M |
|
$-2.08M |
|
$-2.08M |
|
$-2.08M |
|
$0.69M |
|
$0.85M |
|
63.87M |
|
63.87M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$4.79M |
|
$0.13M |
|
$15.97M |
|
$20.76M |
|
|
Current Liabilities |
$64.17M |
$2.26M |
|
$16.07M |
|
$80.24M |
|
$-59.49M |
|
$-59.49M |
|
$-59.49M |
|
63.87M |
|
| Cash Flow Statement Financials | |
$-2.22M |
|
$2.17M |
|
$-1.06M |
|
$1.39M |
|
$0.29M |
|
$-1.10M |
|
$0.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.07 |
|
-- |
|
-- |
|
-0.04 |
|
-0.50 |
|
92.69% |
|
20.57% |
|
20.57% |
|
-- |
|
-44.32% |
|
-61.46% |
|
$-2.22M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.20 |
|
1.29 |
|
69.78 |
|
3.49% |
|
3.49% |
|
-10.00% |
|
3.63% |
|
$-0.93 |
|
$-0.03 |
|
$-0.03 |
|